
RXO Announces First-Quarter Results, Successful Migration of Coyote Coverage Operations to the RXO Connect ® Platform
CHARLOTTE, N.C.--(BUSINESS WIRE)--RXO (NYSE: RXO) today reported its first-quarter financial results and announced the successful migration of Coyote coverage operations to the RXO Connect ® platform.
'Our technology team has been working diligently to integrate the best features of the legacy Coyote technology platform into RXO Connect. Today, I'm pleased to announce a critical integration milestone – carrier and coverage operations are now happening in one system, which will enable us to leverage our scale and realize future cost-of-purchased-transportation synergies,' said Drew Wilkerson, chief executive officer of RXO. 'We have made significant progress with the integration of Coyote and are again raising our synergy estimate. We now expect cash synergies to be more than $70 million. This estimate does not include cost-of-purchased-transportation opportunities, which we expect will be significant.'
Wilkerson said, 'In the first quarter, RXO grew less-than-truckload brokerage volume by 26% year-over-year and saw continued momentum within Last Mile, which achieved stop growth of 24% year-over-year. RXO is well positioned for the long term because of our larger scale, exceptional service, comprehensive solutions, industry-leading innovation and deep customer relationships.'
Companywide Results
RXO's revenue was $1.4 billion for the first quarter, compared to $913 million in the first quarter of 2024. Gross margin was 16.0%, compared to 17.4% in the first quarter of 2024.
The company reported a first-quarter 2025 GAAP net loss of $31 million, compared to a net loss of $15 million in the first quarter of 2024. The first-quarter 2025 GAAP net loss included $20 million in transaction, integration, restructuring and other costs. Adjusted net loss in the quarter was $5 million, compared to an adjusted net loss of $4 million in the first quarter of 2024.
Adjusted EBITDA was $22 million, compared to $15 million in the first quarter of 2024. Adjusted EBITDA margin was 1.5%, compared to 1.6% in the first quarter of 2024.
Transaction, integration, restructuring and other costs, and amortization of intangibles, impacted GAAP earnings per share by $0.15, net of tax. For the first quarter, RXO reported a GAAP diluted loss per share of $0.18. Adjusted diluted loss per share was $0.03.
Brokerage
Volume in RXO's Brokerage business, including the impact of the Coyote Logistics acquisition in both periods, declined by 1% year-over-year in the first quarter. Less-than-truckload volume increased by 26% but was offset by an 8% decline in full truckload volume.
Brokerage gross margin was 13.3% in the first quarter.
Complementary Services
Managed Transportation increased the synergy loads provided to Brokerage.
Last Mile stops grew by 24% year-over-year.
RXO's complementary services gross margin was 21.0% for the quarter.
Second-Quarter Outlook
RXO expects second-quarter 2025 adjusted EBITDA to be between $30 million and $40 million. The company expects second-quarter 2025 Brokerage gross margin to be between 13% and 15%.
Conference Call
The company will hold a conference call and webcast on Wednesday, May 7 at 8 a.m. Eastern Daylight Time. Participants can call in toll-free (from U.S./Canada) at 1-800-549-8228; international callers dial +1-289-819-1520. The conference ID is 81237.
A live webcast of the conference call will be available on the investor relations area of the company's website, http://investors.rxo.com. A replay of the conference call will be available through May 14, 2025, by calling toll-free (from U.S./Canada) 1-888-660-6264; international callers dial +1-289-819-1325. Use the passcode 81237#. Additionally, the call will be archived on http://investors.rxo.com.
About RXO
RXO (NYSE: RXO) is a leading provider of asset-light transportation solutions. RXO offers tech-enabled truck brokerage services together with complementary solutions including managed transportation, freight forwarding and last mile delivery. The company combines massive capacity and cutting-edge technology to move freight efficiently through supply chains across North America. The company is headquartered in Charlotte, N.C. Visit RXO.com for more information and connect with RXO on Facebook, X, LinkedIn, Instagram and YouTube.
Non-GAAP Financial Measures
We provide reconciliations of the non-GAAP financial measures contained in this release to the most directly comparable measure under GAAP, which are set forth in the financial tables attached to this release.
The non-GAAP financial measures in this release include: adjusted earnings before interest, taxes, depreciation and amortization ('adjusted EBITDA'); adjusted EBITDA margin; and adjusted net loss and adjusted diluted loss per share ('adjusted EPS').
We believe that these adjusted financial measures facilitate analysis of our ongoing business operations because they exclude items that may not reflect, or are unrelated to, RXO's core operating performance, and may assist investors with comparisons to prior periods and assessing trends in our underlying businesses. Other companies may calculate these non-GAAP financial measures differently, and therefore our measures may not be comparable to similarly titled measures of other companies. These non-GAAP financial measures should only be used as supplemental measures of our operating performance.
Adjusted EBITDA, adjusted EBITDA margin, adjusted net loss and adjusted EPS include adjustments for transaction and integration costs, as well as restructuring costs and other adjustments as set forth in the attached tables. Management uses these non-GAAP financial measures in making financial, operating and planning decisions and evaluating RXO's ongoing performance.
We believe that adjusted EBITDA and adjusted EBITDA margin improve comparability from period to period by removing the impact of our capital structure (interest and financing expenses), asset base (depreciation and amortization), tax impacts and other adjustments that management has determined do not reflect our core operating activities and thereby assist investors with assessing trends in our underlying business. We believe that adjusted net loss and adjusted EPS improve the comparability of our operating results from period to period by removing the impact of certain costs that management has determined do not reflect our core operating activities, including amortization of acquisition-related intangible assets, transaction and integration costs, restructuring costs and other adjustments as set out in the attached tables, and thereby may assist investors with comparisons to prior periods and assessing trends in our underlying business.
With respect to our financial outlook for the second quarter of 2025 adjusted EBITDA, a reconciliation of this non-GAAP measure to the corresponding GAAP measure is not available without unreasonable effort due to the variability and complexity of the reconciling items described above that we exclude from this non-GAAP measure. The variability of these items may have a significant impact on our future GAAP financial results and, as a result, we are unable to prepare the forward-looking statement of income and statement of cash flows prepared in accordance with GAAP that would be required to produce such a reconciliation.
Forward-looking Statements
This release includes forward-looking statements, including statements relating to our outlook, integration with Coyote Logistics and cash synergies. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, forward-looking statements can be identified by the use of forward-looking terms such as "anticipate," "estimate," "believe," "continue," "could," "intend," "may," "plan," "predict," "should," "will," "expect," "project," "forecast," "goal," "outlook," "target,' or the negative of these terms or other comparable terms. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements are based on certain assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate in the circumstances.
These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause or contribute to a material difference include the risks discussed in our filings with the SEC and the following: the effect of the completion of the transaction to acquire Coyote Logistics on the parties' business relationships and business generally; competition and pricing pressures; economic conditions generally; fluctuations in fuel prices; increased carrier prices; severe weather, natural disasters, terrorist attacks or similar incidents that cause material disruptions to our operations or the operations of the third-party carriers and independent contractors with which we contract; our dependence on third-party carriers and independent contractors; labor disputes or organizing efforts affecting our workforce and those of our third-party carriers; legal and regulatory challenges to the status of the third-party carriers with which we contract, and their delivery workers, as independent contractors, rather than employees; our ability to develop and implement suitable information technology systems and prevent failures in or breaches of such systems; the impact of potential cyber-attacks and information technology or data security breaches; issues related to our intellectual property rights; our ability to access the capital markets and generate sufficient cash flow to satisfy our debt obligations; litigation that may adversely affect our business or reputation; increasingly stringent laws protecting the environment, including transitional risks relating to climate change, that impact our third-party carriers; governmental regulation and political conditions; our ability to attract and retain qualified personnel; our ability to successfully implement our cost and revenue initiatives and other strategies; our ability to successfully manage our growth; our reliance on certain large customers for a significant portion of our revenue; damage to our reputation through unfavorable publicity; our failure to meet performance levels required by our contracts with our customers; the inability to achieve the level of revenue growth, cash generation, cost savings, improvement in profitability and margins, fiscal discipline, or strengthening of competitiveness and operations anticipated or targeted; a determination by the IRS that the distribution or certain related separation transactions should be treated as taxable transactions; and the impact of the separation on our businesses, operations and results. All forward-looking statements set forth in this release are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations. Forward-looking statements set forth in this release speak only as of the date hereof, and we do not undertake any obligation to update forward-looking statements to reflect subsequent events or circumstances, changes in expectations or the occurrence of unanticipated events, except to the extent required by law.
RXO, Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
March 31,
(Dollars in millions, shares in thousands, except per share amounts)
2025
2024
ASSETS
Current assets
Cash and cash equivalents
$
16
$
35
Accounts receivable, net of $11 and $13 in allowances, respectively
1,150
1,227
Other current assets
89
77
Total current assets
1,255
1,339
Long-term assets
Property and equipment, net of $333 and $317 in accumulated depreciation, respectively
143
135
Operating lease assets
256
276
Goodwill
1,124
1,123
Identifiable intangible assets, net of $134 and $146 in accumulated amortization, respectively
484
499
Other long-term assets
42
42
Total long-term assets
2,049
2,075
Total assets
$
3,304
$
3,414
LIABILITIES AND EQUITY
Current liabilities
Accounts payable
$
498
$
568
Accrued expenses
358
373
Short-term debt and current maturities of long-term debt
17
17
Short-term operating lease liabilities
80
81
Other current liabilities
11
26
Total current liabilities
964
1,065
Long-term liabilities
Long-term debt and obligations under finance leases
387
351
Deferred tax liabilities
77
88
Long-term operating lease liabilities
201
215
Other long-term liabilities
88
83
Total long-term liabilities
753
737
Commitments and Contingencies
Equity
Preferred stock, $0.01 par value; 10,000 shares authorized; 0 shares issued and
outstanding as of March 31, 2025 and December 31, 2024
—
—
Common stock, $0.01 par value; 300,000 shares authorized; 163,912 and 162,517
shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively
2
2
Additional paid-in capital
1,908
1,904
Accumulated deficit
(315
)
(284
)
Accumulated other comprehensive loss
(8
)
(10
)
Total equity
1,587
1,612
Total liabilities and equity
$
3,304
$
3,414
Expand
RXO, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Three Months Ended March 31,
(In millions)
2025
2024
Operating activities
Net loss
$
(31
)
$
(15
)
Adjustments to reconcile net loss to net cash from operating activities
Depreciation and amortization expense
32
16
Stock compensation expense
7
5
Deferred tax benefit
(11
)
(7
)
Impairment of operating lease assets
4
—
Other
2
2
Changes in assets and liabilities
Accounts receivable
76
27
Other current assets and other long-term assets
(10
)
(1
)
Accounts payable
(56
)
(41
)
Accrued expenses, other current liabilities and other long-term liabilities
(15
)
21
Net cash provided by (used in) operating activities
(2
)
7
Investing activities
Payment for purchases of property and equipment
(15
)
(11
)
Business acquisition, net of cash acquired
(10
)
—
Net cash used in investing activities
(25
)
(11
)
Financing activities
Proceeds from borrowings on revolving credit facilities
300
39
Repayment of borrowings on revolving credit facilities
(265
)
(31
)
Payment for tax withholdings related to vesting of stock compensation awards
(17
)
(2
)
Other
(11
)
—
Net cash provided by financing activities
7
6
Effect of exchange rates on cash, cash equivalents and restricted cash
1
—
Net increase (decrease) in cash, cash equivalents and restricted cash
(19
)
2
Cash, cash equivalents, and restricted cash, beginning of period
35
5
Cash, cash equivalents, and restricted cash, end of period
$
16
$
7
Supplemental disclosure of cash flow information:
Leased assets obtained in exchange for new operating lease liabilities
$
4
$
23
Cash paid for income taxes, net
1
1
Cash paid for interest, net
2
1
Purchases of property and equipment in accounts payable, accrued expenses and other liabilities
11
2
Accrued tax withholdings related to vesting of stock compensation awards
1
—
Expand
RXO, Inc.
Revenue Disaggregated by Service Offering
(Unaudited)
Three Months Ended March 31,
(In millions)
2025
2024
Revenue
Truck brokerage
$
1,067
$
564
Last mile
278
232
Managed transportation
137
152
Eliminations
(49
)
(35
)
Total
$
1,433
$
913
Expand
RXO, Inc.
Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDA Margin
(Unaudited)
Three Months Ended March 31,
(In millions)
2025
2024
Reconciliation of Net Loss to Adjusted EBITDA
Net loss
$
(31
)
$
(15
)
Interest expense, net
9
8
Income tax benefit
(8
)
(6
)
Depreciation and amortization expense
32
16
Transaction and integration costs
6
1
Restructuring and other costs
14
11
Adjusted EBITDA (1)
$
22
$
15
Revenue
$
1,433
$
913
Adjusted EBITDA margin (1) (2)
1.5
%
1.6
%
(1) See the 'Non-GAAP Financial Measures' section of the press release.
(2) Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by Revenue.
Expand
RXO, Inc.
Reconciliation of Net Loss to Adjusted Net Loss and Adjusted Diluted Loss Per Share
(Unaudited)
Three Months Ended March 31,
(Dollars in millions, shares in thousands, except per share amounts)
2025
2024
Reconciliation of Net Loss to Adjusted Net Loss and Adjusted Diluted Loss Per Share
Net loss
$
(31
)
$
(15
)
Amortization of intangible assets
15
3
Transaction and integration costs
6
1
Restructuring and other costs
14
11
Income tax associated with adjustments above (1)
(9
)
(4
)
Adjusted net loss (2)
$
(5
)
$
(4
)
Adjusted diluted loss per share (2)
$
(0.03
)
$
(0.03
)
Weighted-average shares outstanding
Diluted
168,023
117,217
(1) The tax impact of non-GAAP adjustments represents the tax benefit (expense) calculated using the applicable statutory tax rate that would have been incurred had these adjustments been excluded from net income (loss). Our estimated tax rate on non-GAAP adjustments may differ from our GAAP tax rate due to differences in the methodologies applied.
(2) See the 'Non-GAAP Financial Measures' section of the press release.
Expand
RXO, Inc.
Calculation of Gross Margin and Gross Margin as a Percentage of Revenue
(Unaudited)
Three Months Ended March 31,
(Dollars in millions)
2025
2024
Revenue
Truck brokerage
$
1,067
$
564
Complementary services (1)
415
384
Eliminations
(49
)
(35
)
Revenue
$
1,433
$
913
Cost of transportation and services (exclusive of depreciation and amortization)
Truck brokerage
$
924
$
484
Complementary services (1)
278
250
Eliminations
(49
)
(35
)
Cost of transportation and services (exclusive of depreciation and amortization)
$
1,153
$
699
Direct operating expense (exclusive of depreciation and amortization)
Truck brokerage
$
1
$
—
Complementary services (1)
47
53
Direct operating expense (exclusive of depreciation and amortization)
$
48
$
53
Direct depreciation and amortization expense
Truck brokerage
$
—
$
—
Complementary services (1)
3
2
Direct depreciation and amortization expense
$
3
$
2
Gross margin
Truck brokerage
$
142
$
80
Complementary services (1)
87
79
Gross margin
$
229
$
159
Gross margin as a percentage of revenue
Truck brokerage
13.3
%
14.2
%
Complementary services (1)
21.0
%
20.6
%
Gross margin as a percentage of revenue
16.0
%
17.4
%
(1) Complementary services include last mile and managed transportation services.
Expand
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
an hour ago
- Forbes
Buy Or Fear Oil-Dri Of America Stock
Oil-Dri of America (NYSE:ODC) stock appears appealing – making it a wise choice for purchase at its present price of approximately $55. We have identified some minor issues with ODC stock, which makes it enticing given that its current valuation seems low. Our conclusion is drawn from comparing the current valuation of ODC stock to its operational performance in recent years, as well as its current and historical financial state. Our analysis of Oil-Dri of America across key parameters of Growth, Profitability, Financial Stability, and Downturn Resilience indicates that the company exhibits a robust operating performance and financial status, as clarified below. However, for those investors who prefer lower volatility than individual stocks, the Trefis High Quality Portfolio offers an alternative – having outperformed the S&P 500 and yielded returns surpassing 91% since its inception. In terms of what you pay for each dollar of sales or profit, ODC stock appears somewhat inexpensive when compared to the wider market. • Oil-Dri of America has a price-to-sales (P/S) ratio of 1.5 compared to a figure of 3.0 for the S&P 500 • Additionally, the company's price-to-free cash flow (P/FCF) ratio stands at 9.5 in contrast to 20.5 for the S&P 500 • Furthermore, it holds a price-to-earnings (P/E) ratio of 15.5 compared to the benchmark's 26.4 Oil-Dri of America's Revenues have experienced significant growth in recent years. • Oil-Dri of America has witnessed its top line increase at an average rate of 12.9% over the past 3 years (versus an increase of 5.5% for the S&P 500) • Its revenues have risen 8.2% from $430 million to $465 million in the last 12 months (compared to growth of 5.5% for the S&P 500) • Additionally, its quarterly revenues increased 10.6% to $117 million in the latest quarter from $106 million a year prior (versus a 4.8% rise for the S&P 500) Oil-Dri of America's profit margins are less favorable than those of most companies in the Trefis coverage universe. • Oil-Dri of America's Operating Income over the previous four quarters totaled $62 million, reflecting a moderate Operating Margin of 13.3% (versus 13.2% for the S&P 500) • Oil-Dri of America's Operating Cash Flow (OCF) during this period was $75 million, indicating a moderate OCF Margin of 16.1% (compared to 14.9% for the S&P 500) • For the last four-quarter period, Oil-Dri of America's Net Income was $46 million – suggesting a poor Net Income Margin of 9.8% (relative to 11.6% for the S&P 500) Oil-Dri of America's balance sheet appears solid. • Oil-Dri of America's Debt was reported at $58 million at the conclusion of the most recent quarter, with its market capitalization standing at $762 million (as of 6/6/2025). This creates a strong Debt-to-Equity Ratio of 8.3% (in contrast to 19.9% for the S&P 500). [Note: A low Debt-to-Equity Ratio is preferable] • Cash (along with cash equivalents) comprises $23 million of the $354 million in Total Assets for Oil-Dri of America. This leads to a moderate Cash-to-Assets Ratio of 6.4% (compared to 13.8% for the S&P 500) ODC stock has experienced a slightly better impact than the benchmark S&P 500 index during certain recent downturns. While investors remain optimistic about a soft landing for the U.S. economy, what might the consequences be if another recession occurs? Our dashboard How Low Can Stocks Go During A Market Crash illustrates how key stocks performed during and after the last six market crashes. • ODC stock dropped 41.5% from a peak of $19.23 on 11 March 2021 to $11.24 on 11 October 2022, compared to a peak-to-trough decline of 25.4% for the S&P 500 • The stock completely recovered to its pre-Crisis peak by 9 March 2023 • Since then, the stock has risen to a high of $54.82 on 8 June 2025 • ODC stock decreased 24.6% from a high of $19.19 on 16 January 2020 to $14.46 on 16 March 2020, compared to a peak-to-trough decline of 33.9% for the S&P 500 • The stock fully recovered to its pre-Crisis peak by 11 March 2021 • ODC stock declined 49.4% from a high of $11.47 on 10 December 2007 to $5.81 on 10 October 2008, in contrast to a peak-to-trough decline of 56.8% for the S&P 500 • The stock fully recovered to its pre-Crisis peak by 17 June 2010 In conclusion, Oil-Dri of America's performance across the parameters outlined above is as follows: • Growth: Very Strong • Profitability: Weak • Financial Stability: Strong • Downturn Resilience: Neutral • Overall: Neutral When considered alongside its low valuation, this renders the stock appealing, supporting our assessment that ODC represents a wise stock to purchase. Although ODC stock appears promising, investing in a single stock bears its risks. Conversely, the Trefis High Quality (HQ) Portfolio, which consists of 30 stocks, has a proven track record of comfortably outperforming the S&P 500 over the past 4 years. What accounts for this? As a collective, HQ Portfolio stocks have delivered superior returns with reduced risk compared to the benchmark index; providing a smoother experience as demonstrated in HQ Portfolio performance metrics.
Yahoo
an hour ago
- Yahoo
Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company
UPPSALA, SE / / June 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in blood-based cancer monitoring, has signed a new Master Service Agreement (MSA) - along with an initial Work Order of ~800 kSEK - with a Tier-1 US-based biopharmaceutical company. The new customer, a global leader in oncology drug development, becomes the fifth Tier-1 US biopharma company to join Biovica's Pharma Services customer base. The agreement covers testing of Phase 1 clinical trial samples in support of the development of next-generation CDK4/6 inhibitors and is a pilot study with DiviTum® TKa. " This marks a milestone in our growing customer base, highlighting the increasing relevance of Biovica's TKa biomarker assay in advanced cancer therapy development. It demonstrates the strong and growing recognition of the value our assay brings to the development of next-generation oncology treatments that ultimately benefit cancer patients. ," said Anders Rylander, CEO of Biovica. Contact Anders Rylander, CEOPhone: +46 76 666 16 47E-mail: Anders Morén, CFOPhone: +46 73 125 92 46E-mail: Biovica - Treatment decisions with greater confidence Biovica develops and commercializes blood-based biomarker assays that help oncologists monitor cancer progression. Biovica's assay, DiviTum® TKa, measures cell proliferation by detecting the TKa biomarker in the bloodstream. The assay has demonstrated its ability to provide insight to therapy effectiveness in several clinical trials. The first application for the DiviTum® TKa test is treatment monitoring of patients with metastatic breast cancer. Biovica's vision is: "Improved care for cancer patients." Biovica collaborates with world-leading cancer institutes and pharmaceutical companies. DiviTum® TKa has received FDA 510(k) clearance in the US and is CE-marked in the EU. Biovica's shares are traded on the Nasdaq First North Premier Growth Market (BIOVIC B). FNCA Sweden AB is the company's Certified Adviser. For more information, please visit: Attachments Biovica signs agreement with fifth Tier-1 US biopharma company SOURCE: Biovica International View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
United Healthcare: Earnings, A $200 Billion Overreaction
One of the most dramatic reactions from the Q1 2025 earnings season came from United Healthcare (NYSE:UNH), which shed over $200 billion in market cap and cratered 23% intra-day post-earnings along with continued decline upon the resignation of its CEO and a potential DOJ inquiry. At first glance, that kind of move suggests something catastrophic although the actual results paint a very different picture. Warning! GuruFocus has detected 4 Warning Sign with UNH. The selloff was driven by a 2% increase in Medicare Advantage costs and higher utilization trends (greater related medical expenses), which led to a reduction in 2025 earnings guidance from $29 to $26 per share initially and later with guidance lifted. That's collectively a $3 hit to EPS which is material from initial guidance, but not earth-shattering especially considering UNH is stil projected to have 20.65 billion in 2024 full year net income based on revisions of major investment banks aggregated by Refinitiv along with 25-30 billion for FY26. That level of profit implies a P/E of roughly 12 and a forward P/E of less than 10 (representing a forward cash flow yield of 10%, a truly absurd financial metric for a company of this size), which is deeply discounted for a business of this scale, profitability, and consistency. The increase in utilization is also expected within the earnings call to normalize to historical averages in the near future and this isn't the first time a Medicare Advantage utilization has caused the share price to decline. In June 2023 a similar utilization increase was seen and the effects were short lived, negligible to profitability and the share price quickly was achieving new highs just a six weeks later. Given how the insurance operation works, premiums can also be raised to offset additional care expenses encountered to maintain similar margins and levels of profitability. The CEO also stepped down due to stated personal reasons, while for investors having a CEO step down is typically seen as something negative, the successor for the position is the long term prior CEO Steven J Hemsley, an executive that oversaw exceptional increases in financial operations, efficiency, and stewardship of the company through industry opportunities. While the stock declined rather significantly upon his appointment, this would seem to be dramatic given the prior CEO executed incredible shareholder returns and growth of operations. The last contributor to major negative sentiment is the "announcement/accusation" by journalists a DOJ probe into medicare advantage billing escalating from civil to criminal (uncorroborated by the DOJ or any legal agency), the company explicitly denied any knowledge or informational requests related to such a probe or its supposed existence and given a prior legal ruling in the civil case that there was no apparent incorrect coding for billing, the legitimacy of this seems to be in question. While if the probe is found to be legitimate in the future, as incredible as it sounds, the company would also likely not have any difficulty financing a fine/outlay of significant size. UNH generates profits from a few large business segments albeit diversified due to the massive scale, the insurance operation in which premiums are received and invested/used to pay out claims respectfully and represents the largest health insurer in the US. The other major component of business operations is Optum, which consists of its pharmacy benefit manager operations, Optum Health which directs healthcare directly, and Optum Insights which provides data analytics and consulting. The hit to guidance was within the legacy insurance segment, which remains wildly profitable although the real driver of earnings growth (a greater than 50% share of net income) is seen within Optum which would seem to be unaffected. UNH's capital allocation strategy has historically been a masterclass in shareholder returns. The company has averaged 2-4 billion in quarterly stock buybacks, while simultaneously paying out close to $8 billion in annual dividends all without compromising operations or balance sheet strength. The most recent buyback spike in Q4 2024 was nearly $5 billion, the largest in the past three years. Based on the outlandish profitability of UNH and the businesses clear willingness and ability to reward shareholders, once you throw in the fact that there is a significant discount being placed on the business by the market, it becomes clear this is a sizable overreaction and not reflective of the operations or strength of the company. *historically repurchases accelerate for UNH under market declines This level of profitability and shareholder alignment is rare, and it's even more compelling now that the market has mispriced the stock on short-term guidance noise. The biggest opportunities in investing often come when price temporarily detaches from financial reality and that's exactly what this looks like. With the regime of a current market built on fear and facing macroeconomic struggles, health insurance is generally considered a defensive, non-cyclical industry because demand for healthcare remains relatively stable regardless of economic conditions. People don't stop needing medical care during a recession and if anything, economic stress can drive higher Medicaid enrollment or subsidized marketplace coverage. For insurers like UNH, revenue is largely tied to premiums and government reimbursements, which are contractual or regulated and don't fluctuate with consumer sentiment or discretionary spending trends. Even during downturns, enrollment can remain stable or even grow as individuals shift from employer-sponsored plans to government-backed options. Unlike cyclical sectors like consumer discretionary or industrials, healthcare spending is inelastic and people prioritize it no matter what. Moreover, Medicare Advantage and Medicaid, which are a large part of UNH's book, are government-funded and relatively insulated from short-term economic cycles. As for the broader industry landscape, there are no meaningful moves underway to undercut or dismantle the private health insurance model. The regulatory outlook remains stable, and there are no current legislative pressures that would structurally alter the business model of companies like UNH. Importantly, this volatility in premiums is limited to the UnitedHealthcare segment. Optum UNH's faster-growing, higher margin division which continues to deliver strong performance across health services, pharmacy benefits, and data analytics. Together, this structure gives UNH a diversified revenue model that can weather temporary shocks in one segment without compromising overall earnings power and represents a significantly undervalued equity at current market prices. * TipRanks. (n.d.). UnitedHealth (NYSE:UNH) stock buybacks. Retrieved May 3, 2025, from This article first appeared on GuruFocus.